Isometric Preoperative Exercise on Autologous Arteriovenous Fistulas. Randomized Clinical Trial
Launched by HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑON · Jul 10, 2017
Trial Information
Current as of July 22, 2025
Completed
Keywords
ClinConnect Summary
RECRUITING PERIOD: 20 months.
FOLLOW UP: From the first preoperative assessment visit for AVF up to 3 months after its creation.
METHODS:
After signing the informed consent, patients will be randomized through a centralized computer program to one of two groups of patients, PIE group versus control group.
In both groups of patients, a first physical examination of upper arm extremities and an initial doppler ultrasound will be performed, evaluating the anatomical and hemodynamic characteristics of the arteries and veins of both arms. At that time, a first surgical option of AVF will be ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Informed consent signature.
- • Age between 18 and 89 years.
- • Patients with advanced chronic kidney disease, stages IV-V, in pre-dialysis or prevalent HD patients, requiring new AVF.
- Exclusion Criteria:
- • Absence of adequate arteries and veins to allow autologous AVF. (The minimum gauges that will be considered in order to perform an autologous AVF are: artery caliber equal or greater than 1.6 mm and vein caliber equal or greater than 1,8 mm with a compressor).
- • Diagnosis of coagulopathy or hemoglobinopathy of any cause.
- • Patients who urgently need an AVF without the possibility of being 8 weeks on the surgical waiting list.
- • Impossibility to perform the physical exercise protocol due to physical or mental disabilities or lack of social support.
About Hospital General Universitario Gregorio Marañon
The Hospital General Universitario Gregorio Marañón is a leading healthcare institution located in Madrid, Spain, renowned for its commitment to clinical excellence and innovative research. As a prominent clinical trial sponsor, the hospital combines advanced medical practices with cutting-edge research methodologies to facilitate the development of new therapies and improve patient outcomes. With a multidisciplinary team of experts and state-of-the-art facilities, the hospital actively engages in a wide range of clinical trials, contributing to the advancement of medical knowledge and the enhancement of healthcare delivery both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madrid, , Spain
Patients applied
Trial Officials
INES ARAGONCILLO, MD
Principal Investigator
GREGORIO MARAÑON HOSPITAL
ALMUDENA VEGA, MD PHD
Study Chair
GREGORIO MARAÑON HOSPITAL
SORAYA ABAD, MD
Study Chair
GREGORIO MARAÑON HOSPITAL
NICOLAS MACIAS, MD
Study Chair
GREGORIO MARAÑON HOSPITAL
JOSE MANUEL LIGERO, MD
Study Chair
GREGORIO MARAÑON HOSPITAL
ROSARIO GARCIA PAJARES, MD
Study Chair
GREGORIO MARAÑON HOSPITAL
ANGEL LUIS MORALES, MD
Study Chair
GREGORIO MARAÑON HOSPITAL
TERESA CERVERA, MD
Study Chair
GREGORIO MARAÑON HOSPITAL
JAVIER RIO, MD
Study Chair
GREGORIO MARAÑON HOSPITAL
DIEGO RUIZ CHIRIBOGA, MD
Study Chair
GREGORIO MARAÑON HOSPITAL
ELENA MENENDEZ, MD
Study Chair
GREGORIO MARAÑON HOSPITAL
MARTA ALBALATE, MD PHD
Study Chair
HOSPITAL INFANTA LEONOR
JARA AMPUERO, MD
Study Chair
HOSPITAL DEL SURESTE
COVADONGA HEVIA, MD
Study Chair
Hospital Infanta Sofia
SILVIA CALDES, MD
Study Chair
Hospital Infanta Sofia
YESIKA AMEZQUITA, MD
Study Chair
Hospital Infanta Sofia
YOLANDA HERNANDEZ, MD
Study Chair
Hospital Infanta Sofia
CRISTINA MORATILLA, MD PHD
Study Chair
CLINICA FUENSANTA
CARMEN CABRE, MD
Study Chair
CLINICA FUENSANTA
JOSE LUIS MARTIN CONTY
Study Chair
CASTILLA LA MANCHA UNIVERSITY
CRISTINA FERNANDEZ, MD PHD
Study Chair
Hospital Clinico de Madrid
ISRAEL LEBLIC, MD
Study Chair
Hospital Universitario La Paz
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials